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Abstract
Background: This study uses surveillance, survey and program data to estimate past trends and current levels of HIV in
Botswana and the effects of treatment and prevention programs.
Methods/Principal Findings: Data from sentinel surveillance at antenatal clinics and a national population survey were used
to estimate the trend of adult HIV prevalence from 1980 to 2007. Using the prevalence trend we estimated the number of
new adult infections, the transmission from mothers to children, the need for treatment and the effects of antiretroviral
therapy (ART) and adult and child deaths. Prevalence has declined slowly in urban areas since 2000 and has remained stable
in rural areas. National prevalence is estimated at 26% (25–27%) in 2007. About 330,000 (318,000–335,000) people are
infected with HIV including 20,000 children. The number of new adult infections has been stable for several years at about
20,000 annually (12,000–26,000). The number of new child infections has declined from 4600 in 1999 to about 890 (810–980)
today due to nearly complete coverage of an effective program to prevent mother-to-child transmission (PMTCT). The
annual number of adult deaths has declined from a peak of over 15,500 in 2003 to under 7400 (5000–11,000) today due to
coverage of ART that reaches over 80% in need. The need for ART will increase by 60% by 2016.
Conclusions: Botswana’s PMTCT and treatment programs have achieved significant results in preventing new child
infections and deaths among adults and children. The number of new adult infections continues at a high level. More
effective prevention efforts are urgently needed.
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Introduction
Botswana has one of the highest levels of HIV in the world.
UNAIDS estimated that adult prevalence was about 24% in 2005,
higher than any other country except Swaziland [1]. The epidemic
has imposed a terrible burden due to lives lost, reduced quality of
life and a large number of orphans. Since 2003 Botswana and its
development partners have launched strong efforts to prevent the
transmission of HIV from mothers to their children and to provide
advanced treatment to those who need it. Information on
epidemic trends is available from sentinel surveillance conducted
annually at antenatal clinics around the country. Program statistics
describe the expansion of the PMTCT and treatment programs
[2].
Comprehensive assessments of the demographic impact of the
epidemic were conducted for Botswana in 2000 [3] and 2006 [4].
This report expands and updates those analyses using the latest
surveillance and program data as well as updated models
developed by UNAIDS. It describes the use of these data to
estimate national prevalence in Botswana and to assess the
implications of that estimate for other indicators of interest, such as
the number of people infected, the annual number of new
infections, the number of people in need of ART, and the impact
of the PMTCT and treatment programs.
Methods
The HIV surveillance program conducts annual HIV surveys
among women aged 15–49 years attending ante-natal clinics.
Surveillance has been conducted annually since 1992 and now
includes 24 sites [5]. Since these surveys measure HIV prevalence
in pregnant women they do not represent prevalence in all adults,
including both men and women. However, since ANC surveil-
lance is conducted annually it does provide information on trends
in prevalence that should be representative of those in the general
adult population.
The Botswana AIDS Impact Survey II (BAIS II) conducted in
2004 measured the prevalence of HIV infection in the population
aged 18 months and above [6]. Although only 61% of those
interviewed in this survey agreed to provide a blood sample for
HIV testing, the results of this survey are thought to provide a
reasonably accurate measure of HIV prevalence in 2004.
The UNAIDS Reference Group on Estimates, Models and
Projections has developed several tools to estimate national
prevalence. One of these tools, the Estimation and Projection
Package (EPP), is used in most countries in sub-Saharan Africa to
estimate prevalence trends from surveillance and survey data in
countries with generalized epidemics [7]. EPP works by fitting a
simple epidemic model to surveillance data from multiple sites
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prevalence and then combined to produce a national estimate.
The epidemic model uses four parameters to determine the
prevalence trend over time: the start year of the epidemic, the
initial force of infection, the proportion of the population at risk of
infection and the rate of replenishment of the population at risk
when it is depleted by AIDS deaths. EPP generates 50,000 to
200,000 epidemic curves by randomly selecting values of these
four parameters from plausible distributions. Each of these curves
is tested to see how well it fits the surveillance and survey data. A
sample of curves is drawn from the full set with the likelihood of
selection proportional to the goodness of fit. The result is a most
likely curve that provides a point estimate of prevalence in each
year and a range around the point estimate.
The estimates of adult HIV prevalence are used in the AIDS
module of Spectrum [8] to estimate the other indicators of interest
such as the number of people living with HIV, new infections,
AIDS deaths, need for treatment and the number of orphans. HIV
prevalence among adults 15–49 is combined with information on
the age and sex distribution of prevalence from the national survey
to estimate the distribution of prevalent adult infections by age and
sex. The trend in prevalence is combined with information on the
distribution of time from infection to AIDS death from cohort
studies to estimate the number of new adult infections by age and
sex. New infant infections are estimated from prevalence among
pregnant women and the rate of mother-to-child transmission,
which is dependent on infant feeding practices and the coverage of
prophylaxis with ARVs. New infections progress over time to a
symptomatic stage where ART is needed.
The rate of progression from infection to AIDS death for adults
is a distribution drawn from cohort studies in sub-Saharan Africa
[9]. The median time from infection to AIDS death without
treatment is 11 years. Eligibility for ART is assumed to occur at a
median of three years before AIDS death [10]. Those who receive
first- and/or second-line ART experience extended survival. In
Botswana, program data are available on the proportion of ART
patients who are known to be alive by time since the initiation of
therapy. As of December 2007 information is available on 75,393
patients. These data show that after 12 months, 91.3% of ART
patients are known to be still alive, and after five year 86% of ART
patients are still alive. These rates mayoverstate the true survival
since some of those who were lost to follow-up (i.e. their status is
unknown) have probably died. The UNAIDS Reference Group on
Estimates, Models and Projections assumes that for most new
programs the annual survival rates are 85% for the first year on
ART and 95% for subsequent years [10]. However, the first year
survival is likely to be lower in new programs with low ART
coverage since most patients get started on ART very late, with
low CD4 counts. When coverage is high as in Botswana patients
are identified as being in need earlier and generally start ART at
higher CD4 counts which should result in better first year survival.
People at any stage are subject to non-AIDS mortality at the
same rates as those who are not infected. The progression of
children from infection to AIDS death is modeled as a double
Weibull curve fitted to longitudinal data [11]. AIDS and non-
AIDS orphans are estimated from the number of adult deaths each
year, the fertility history of those who die and the rates of child
survival.
Spectrum estimates the uncertainty around the estimate of each
indicator by using a Monte Carlo approach. One thousand
projections are calculated using different prevalence curves
provided by EPP and drawing random values of other key
parameters (such as the progression time to AIDS death, and the
effectiveness of ART) for each projection. The results are analyzed
to produce 5% and 95% plausibility bounds around each point
estimate. (These are not true confidence intervals since the errors
around the input assumptions are not measured directly and we
cannot include all sources of error.)
Results
Results for key HIV/AIDS indicators are shown in Table 1.
The plausibility bounds for prevalence and number of adults
infected are narrow because the national survey provided an
accurate estimate of the level of infection in 2004. Bounds for
other indicators rely on additional assumptions, such as the
progression period from infection to death and the effects of ART
and PMTCT and, therefore, are wider.
Prevalent Adult HIV Infections
HIV trends at antenatal surveillance sites are shown for urban
and rural sites in Figure 1. The best fitting curves to these data
suggest that HIV prevalence has declined somewhat in urban
areas since 2000 and has remained stable in rural areas. These
curves need to be adjusted to match the national population survey
Table 1. Key HIV/AIDS Indicators and Plausibility Bounds,
2007
Indicator Value in 2007 Plausibility Bounds
HIV Adults+Children 330,000 318000–345000
HIV Adults 15+ 311,000 299000–325000
HIV population-Children 19,561 18000–21000
Prevalence Adult 25.7 24.8–26.7
New HIV infections-Adult 18,000 12000–26000
New HIV Infections-Children 890 810–980
Annual AIDS deaths-Adult 7,400 5000–11000
Annual AIDS deaths-Children 790 600–1020
Need for ART-Adult (15+) 120,000 101000–136000
Need for ART-Children 7,400 6800–7800
Mothers needing PMTCT 15,000 13000–16000
AIDS orphans 90,000 76000–103000
doi:10.1371/journal.pone.0003729.t001
Figure 1. HIV prevalence among women attending antenatal
clinics, 1991–2007. Data from urban clinics (Figure 1a) and rural
clinics (Figure 1b) are shown in the gray lines. The smooth curve
produced by EPP is shown in the dark dashed line for each region.
doi:10.1371/journal.pone.0003729.g001
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to account for the bias in urban surveillance sites compared to the
entire urban population. The rural curve needs to be adjusted
downwards by only 15%. In making this adjustment we assume
that the ANC data represent the trend in prevalence and the
national survey best represents the level.
When these curves are adjusted to match the national
population survey of 2004 and weighted by the adult urban and
rural populations they suggest that national prevalence among all
adults 15–49 in Botswana peaked at about 26% in 2001 and has
since declined slightly to 25.7% (24.8%–26.7%) by 2007. This
implies that 280,000 adults 15–49 are currently infected, 47% in
urban areas and 53% in rural areas. While the national survey in
2004 found that the peak ages for prevalence were 30–34 for both
men and women, high levels of prevalence persist up to ages 70–
74. When adult infections over the age of 49 are included the total
number of adults infected with HIV is estimated to be about
310,000 (299,000–325,000).
Adult HIV Incidence
The prevalence trend combined with the pattern of progression
from new infection to AIDS death indicates that the annual
number of new adult infections peaked at around 33,000 in 1995
and declined to about 20,000 by 2002 and is currently around
18,000 (12,000–26,000).
Incidence among those 15–49 is declining, from 3.5% in 2000
to 2.4% in 2007. While the overall population growth rate in
Botswana has declined to about 1.7% today, the annual growth
rate among all adults is still 2.4%. Therefore, the overall absolute
number of new infections each year is approximately constant.
Adult AIDS deaths and the effects of ART
The annual number of adult AIDS deaths rose steadily during
the 1980s and 1990s to a peak of nearly 16,000 in 2003. Without
any ART program adult AIDS deaths would have continued
increasing to nearly 23,000 in 2007. However, Botswana has
implemented a vigorous treatment program that has expanded the
number of adults receiving ART from 932 in 2000 to 85,497 by
the end of 2007, about 83% of need [11]. As a result the estimated
number of adult AIDS deaths has dropped to 7400 (5000–11,000)
in 2007 (Figure 2b). The provision of ART has averted an
estimated 53,000 deaths from 2000 to 2007. If these deaths had
not been averted by ART then AIDS deaths would have exceeded
new infections and adult HIV prevalence would have been much
lower. We estimate that prevalence would have declined to 22.7%
in 2007, three percentage points lower than the actual estimate.
Those currently receiving ART will continue to need it for
many years to come. In addition, about 23,000 adults newly
progress to need for ART each year. As a result the need for ART
is expected to increase by almost 60% from 120,000 (101,000–
136,000) in 2007 to about 190,000 by 2016 if the high levels of
coverage are maintained. This has important cost and sustain-
ability implications for the programme.
Child infections and the effects of PMTCT
The high levels of HIV infection in adults mean that many
children are exposed to the risk of acquiring infection from their
mothers. The estimated number of new infections among children
peaked at around 4600 in 1999. PMTCT services were introduced
in 2002 and coverage expanded rapidly. By 2007 91% of HIV-
positive pregnant women received antiretrovirals to reduce the risk
ofmother-to-child transmission [12].Morethan halfofthesewomen
receive a combination of single dose Nevirapine and AZT. The
program carefully tracks women attending antenatal care and
women giving birth recording HIV status and for those HIV+
women it reports the number of women evaluated for ART, eligible
for ART, already on ART, and use of AZT, Nevirapine and co-
trimoxazole. Since early 2007 the program has tracked outcomes for
children born to HIV-positive mothers by using dried blood spots
and PCR tests on all children born to HIV+ mothers. The results to
date indicate that the program has reduced the average mother-to-
child transmission rate to just 3.7% by 2007 [12]. Using this figure
we estimate that the annual number of new child infections is now
about 890 (810–980) (Figure 2a). The expansion of the PMTCT
program has averted 10,000 child infections from 2002 to 2007.
HIV-positive children have benefited from an expansion of
treatment programs. By the end of 2007 7,400 children were
receiving ART, nearly all those estimated to be in need, and almost
10,000 were receiving co-trimoxazole. As a result child AIDS deaths
have been reduced from about 3,000 in 2001 to 790 (600–1020) in
2007. Nearly 11,000 child deaths have been averted by the
combined effects of PMTCT, child treatment and adult ART.
Orphans
As a result of adult AIDS deaths a significant proportion of
children have lost one or both parents. We estimate that there
were 130,000 (110,000–150,000) orphans in 2007, about 16% of
all children under the age of 18. Three-quarters of these orphans
are due to AIDS. One-third of households caring for orphans are
receiving external support [12]. The success of the adult ART
program has reduced the number of new orphans each year by
40%, from 20,000 in 2002 to 12,000 in 2007.
Discussion
Botswana has an HIV surveillance system and a national HIV
survey that provide the basis for estimates of the extent of the HIV
epidemic and its dynamics. These data indicate that prevalence is
currently declining slightly in urban areas and stable in rural areas.
The estimates produced from these data indicate that the number
of new infections rose rapidly during the early 1990s, peaking in
the mid-1990s before falling to a stable level of about 18,000 new
infections per year today. The number of AIDS deaths started to
grow rapidly about 10 years later than the rise in new infections,
peaking just before the expansion of ART.
The successful expansion of the ART program has increased
coverage to over 80% of those in need of treatment. This
expansion has had significant benefits, reducing the annual
Figure 2. Annual number of new child infections (Figure 2a)
and adult deaths (Figure 2b), 1980–2007.
doi:10.1371/journal.pone.0003729.g002
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in half the number of new orphans each year. The high coverage
of adult ART has also contributed to a reduction in mother-to-
child transmission of HIV.
Duetothehighnumberofnewinfectionsinthepast24,000adults
progress to eligibility for ART each year. As a result, the need for
adult ART will increase by nearly 60% by 2016. This presents a
major challenge to maintain the current levels of high coverage.
The PMTCT program represents a major success with over 90%
of HIV-positive women receiving antiretrovirals to prevent trans-
mission of HIV to their children. The program has averted an
estimated 10,000 child infections since its inception. The combined
effects of the PMTCT program and the child treatment program
have averted an estimated 11,000 child AIDS deaths. With fewer
new child infections the need for child treatment is also be reduced.
Unfortunately similar progress has not been made in reducing
the number of new adult infections (Figure 3). Some prevention
programs have been expanded to scale. Condom use in Botswana
is among the highest anywhere in the world. High coverage has
been achieved for voluntary counseling and testing and AIDS
education in the schools. But these programs have not been
enough to make a significant difference. The proportion of adults
with more than one sexual partner remains very high. A high level
of partner concurrency contributes to rapid reproduction of new
infections. New approaches are urgently needed. At the current
rate of new infections prevalence will remain at very high levels
and the burden to expand treatment programs in the future will
continue to grow.
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